Tag: p53

Articles

• HPV and breast cancer

News

09/02/20

Blueberry compound pterostilbene inhibits mutant p53 breast cancer

02/25/18

Cucumber has anti-cancer activities in ER+, HER2+ and TN cells

02/16/15

Starvation enhances gene expression leading to programmed cell death

Studies

• Active substance and mechanisms of Actinidia chinensis Planch for the treatment of breast cancer was explored based on network pharmacology and in silico study Cite
  Xu Y, Yang J, Han X, Gan C, Wei X. Active substance and mechanisms of Actinidia chinensis Planch for the treatment of breast cancer was explored based on network pharmacology and in silico study. Medicine. Ovid Technologies (Wolters Kluwer Health); 2024; 103:e37829 10.1097/md.0000000000037829
• Exploring the ROS-mediated anti-cancer potential in human triple-negative breast cancer by garlic bulb extract: A source of therapeutically active compounds Cite
  Upadhyay S, Ahmad R, Kumar R, Ghildiyal S, Singh A, Ahmad K, et al. Exploring the ROS-mediated anti-cancer potential in human triple-negative breast cancer by garlic bulb extract: A source of therapeutically active compounds. Journal of Traditional and Complementary Medicine. Elsevier BV; 2024; 10.1016/j.jtcme.2024.04.003
• Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels Cite
  Fathy A, Abdelrazek MA, Attallah AM, Abouzid A, El-Far M. Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-3047606/v1
• 2,2-Diphenethyl Isothiocyanate Enhances Topoisomerase Inhibitor-Induced Cell Death and Suppresses Multi-Drug Resistance 1 in Breast Cancer Cells Cite
  Aggarwal M. 2,2-Diphenethyl Isothiocyanate Enhances Topoisomerase Inhibitor-Induced Cell Death and Suppresses Multi-Drug Resistance 1 in Breast Cancer Cells. Cancers. MDPI AG; 2023; 15:928 10.3390/cancers15030928
• Targeting Y220C mutated p53 by Foeniculum vulgare-derived phytochemicals as cancer therapeutics Cite
  Garg S, Singh J, Verma SR. Targeting Y220C mutated p53 by Foeniculum vulgare-derived phytochemicals as cancer therapeutics. Journal of Molecular Modeling. Springer Science and Business Media LLC; 2023; 29 10.1007/s00894-023-05454-2
• Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumorexplants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways Cite
  Nandi SK, Pradhan A, Das B, Das B, Basu S, Dutta A, et al. Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumorexplants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways. Pathology - Research and Practice. Elsevier BV; 2022;:154029 10.1016/j.prp.2022.154029
• Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells Cite
  O’Grady S, Crown J, Duffy MJ. Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells. Medical Oncology. Springer Science and Business Media LLC; 2022; 39 10.1007/s12032-022-01733-9
• Early Social Enrichment Modulates Tumor Progression and p53 Expression in Adult Mice Cite
  Middei S, Giorgini L, Vacca V, Storri F, Putti S, Strimpakos G, et al. Early Social Enrichment Modulates Tumor Progression and p53 Expression in Adult Mice. Biomolecules. MDPI AG; 2022; 12:532 10.3390/biom12040532
• Mathematical model for the estrogen paradox in breast cancer treatment Cite
  Ouifki R, Oke SI. Mathematical model for the estrogen paradox in breast cancer treatment. Journal of Mathematical Biology. Springer Science and Business Media LLC; 2022; 84 10.1007/s00285-022-01729-z
• Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study Cite
  de Jonge MM, de Kroon CD, Jenner DJ, Oosting J, de Hullu JA, Mourits MJE, et al. Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2021; 113:1203-1211 10.1093/jnci/djab036
• Inflammatory level under different p53 mutation status and the regulation role of curcumin in tumor microenvironment Cite
  Xu L, Xie X, Li X, Duan W, Qiu L, Liu H, et al. Inflammatory level under different p53 mutation status and the regulation role of curcumin in tumor microenvironment. Immunobiology. Elsevier BV; 2022; 227:152177 10.1016/j.imbio.2022.152177
• Green Tea (Camellia sinensis) Extract Induces p53-Mediated Cytotoxicity and Inhibits Migration of Breast Cancer Cells Cite
  Santos RA, Andrade EDS, Monteiro M, Fialho E, Silva JL, Daleprane JB, et al. Green Tea (Camellia sinensis) Extract Induces p53-Mediated Cytotoxicity and Inhibits Migration of Breast Cancer Cells. Foods. MDPI AG; 2021; 10:3154 10.3390/foods10123154
• Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer Cite
  Malla R, Marni R, Chakraborty A, Kamal MA. Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer. Journal of Pharmaceutical Analysis. Elsevier BV; 2021; 10.1016/j.jpha.2021.11.004
• Breast cancer dormancy is associated with a 4NG1 state and not senescence Cite
  Prunier C, Alay A, van Dijk M, Ammerlaan KL, van Gelderen S, Marvin DL, et al. Breast cancer dormancy is associated with a 4NG1 state and not senescence. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00347-0
• Allicin induces cell cycle arrest and apoptosis of breast cancer cells in vitro via modulating the p53 pathway Cite
  Maitisha G, Aimaiti M, An Z, Li X. Allicin induces cell cycle arrest and apoptosis of breast cancer cells in vitro via modulating the p53 pathway. Molecular Biology Reports. Springer Science and Business Media LLC; 2021; 10.1007/s11033-021-06722-1
• Distinct Classes of Flavonoids and Epigallocatechin Gallate, Polyphenol Affects an Oncogenic Mutant p53 Protein, Cell Growth and Invasion in a TNBC Breast Cancer Cell Line Cite
  Kollareddy M, Martinez LA. Distinct Classes of Flavonoids and Epigallocatechin Gallate, Polyphenol Affects an Oncogenic Mutant p53 Protein, Cell Growth and Invasion in a TNBC Breast Cancer Cell Line. Cells. MDPI AG; 2021; 10:797 10.3390/cells10040797
• EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction Cite
  Zhao J, Blayney A, Liu X, Gandy L, Jin W, Yan L, et al. EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction. Nature Communications. Springer Science and Business Media LLC; 2021; 12 10.1038/s41467-021-21258-5
• Identification of key genes of hesperidin in inhibition of breast cancer stem cells by functional network analysis Cite
  Hermawan A, Khumaira A, Ikawati M, Putri H, Jenie RI, Angraini SM, et al. Identification of key genes of hesperidin in inhibition of breast cancer stem cells by functional network analysis. Computational Biology and Chemistry. Elsevier BV; 2020; 90:107427 10.1016/j.compbiolchem.2020.107427
• Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells Cite
  Funakoshi-Tago M, Tago K, Li C, Hokimoto S, Tamura H. Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells. Scientific Reports. Springer Science and Business Media LLC; 2020; 10 10.1038/s41598-020-76445-z
• Capsanthin Stimulates the Mitochondrial Apoptosis-Mediated Cell Death, following DNA Damage in MCF-7 Cells Cite
  Erden Y. Capsanthin Stimulates the Mitochondrial Apoptosis-Mediated Cell Death, following DNA Damage in MCF-7 Cells. Nutrition and Cancer. Informa UK Limited; 2020; 73:662-670 10.1080/01635581.2020.1819347
• Pterostilbene as a Phytochemical Compound Induces Signaling Pathways Involved in the Apoptosis and Death of Mutant P53-Breast Cancer Cell Lines Cite
  Elsherbini AM, Sheweita SA, Sultan AS. Pterostilbene as a Phytochemical Compound Induces Signaling Pathways Involved in the Apoptosis and Death of Mutant P53-Breast Cancer Cell Lines. Nutrition and Cancer. Informa UK Limited; 2020;:1-9 10.1080/01635581.2020.1817513
• Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study Cite
  Benefield HC, Zabor EC, Shan Y, Allott EH, Begg CB, Troester MA. Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2019; 28:1784-1791 10.1158/1055-9965.epi-19-0365
• Hormone-Like Effects of Bisphenol A on p53 and Estrogen Receptor Alpha in Breast Cancer Cells Cite
  Lloyd V, Morse M, Purakal B, Parker J, Benard P, Crone M, et al. Hormone-Like Effects of Bisphenol A on p53 and Estrogen Receptor Alpha in Breast Cancer Cells. BioResearch Open Access. Mary Ann Liebert Inc; 2019; 8:169-184 10.1089/biores.2018.0048
• 17β-estradiol at low concentrations attenuates the efficacy of tamoxifen in breast cancer therapy Cite
  Xu Z, Zheng X, Xia X, Wang X, Luo N, Huang B, et al. 17β-estradiol at low concentrations attenuates the efficacy of tamoxifen in breast cancer therapy. Environmental Pollution. Elsevier BV; 2019; 255:113228 10.1016/j.envpol.2019.113228
• Anti-Estrogenic and Anti-Cell Proliferative Effect of Allyl Isothiocyanate in Chemoprevention of Chemically Induced Mammary Carcinogenesis in Rats Cite
  Thangarasu R, Pachaiappan P, Subbaiyan T. Anti-Estrogenic and Anti-Cell Proliferative Effect of Allyl Isothiocyanate in Chemoprevention of Chemically Induced Mammary Carcinogenesis in Rats. Pathology & Oncology Research. Springer Science and Business Media LLC; 2019; 26:913-925 10.1007/s12253-019-00638-9
• Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins Cite
  Khodabandehlou N, Mostafaei S, Etemadi A, Ghasemi A, Payandeh M, Hadifar S, et al. Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins. BMC Cancer. Springer Science and Business Media LLC; 2019; 19 10.1186/s12885-019-5286-0
• Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer Cite
  Bae SY, Nam SJ, Jung Y, Lee SB, Park B, Lim W, et al. Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 172:437-444 10.1007/s10549-018-4928-2
• Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile Cite
  Takahashi S, Thike AA, Koh VCY, Sasano H, Tan PH. Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile. Virchows Archiv. Springer Science and Business Media LLC; 2018; 473:275-283 10.1007/s00428-018-2416-z
• Abstract B76: High glucose induces breast cancer progression through upregulating PP2Cδ Cite
  Wu K, Yu X, Yi X, Ma L, Elshimali Y, Liu Y, et al. Abstract B76: High glucose induces breast cancer progression through upregulating PP2Cδ. Cell, Molecular, and Tumor Biology. American Association for Cancer Research; 2018; 10.1158/1538-7755.disp17-b76
• Resveratrol prevents p53 aggregation in vitro and in breast cancer cells Cite
  Ferraz da Costa DC, Campos NP, Santos RA, Guedes-da-Silva FH, Martins-Dinis MMD, Zanphorlin L, et al. Resveratrol prevents p53 aggregation in vitro and in breast cancer cells. Oncotarget. Impact Journals, LLC; 2018; 9:29112-29122 10.18632/oncotarget.25631
• Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer Cite
  Otsuka K, Yamamoto Y, Ochiya T. Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer. Oncotarget. Impact Journals, LLC; 2018; 9:24718-24730 10.18632/oncotarget.25339
• Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms Cite
  Gong X, Smith J, Swanson H, Rubin L. Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms. Molecules. MDPI AG; 2018; 23:905 10.3390/molecules23040905
• Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53/Bax/Bcl-2 signaling pathway Cite
  Beberok A, Wrześniok D, Rok J, Rzepka Z, Respondek M, Buszman E. Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53/Bax/Bcl-2 signaling pathway. International Journal of Oncology. Spandidos Publications; 2018; 10.3892/ijo.2018.4310
• P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients Cite
  Pan Y, Yuan Y, Liu G, Wei Y. P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0172324 10.1371/journal.pone.0172324
• p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors Cite
  Chiche A, Moumen M, Romagnoli M, Petit V, Lasla H, Jézéquel P, et al. p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors. Oncogene. Springer Science and Business Media LLC; 2016; 36:2355-2365 10.1038/onc.2016.396
• Apple pectin: A natural source for cancer suppression in 4T1 breast cancer cells in vitro and express p53 in mouse bearing 4T1 cancer tumors, in vivo Cite
  Delphi L, Sepehri H. Apple pectin: A natural source for cancer suppression in 4T1 breast cancer cells in vitro and express p53 in mouse bearing 4T1 cancer tumors, in vivo. Biomedicine & Pharmacotherapy. Elsevier BV; 2016; 84:637-644 10.1016/j.biopha.2016.09.080
• Reactivation of mutant p53 by capsaicin, the major constituent of peppers Cite
  Garufi A, Pistritto G, Cirone M, D’Orazi G. Reactivation of mutant p53 by capsaicin, the major constituent of peppers. Journal of Experimental & Clinical Cancer Research. Springer Science and Business Media LLC; 2016; 35 10.1186/s13046-016-0417-9
• Abstract 215: Metabolic and mitochondrial consequences of p53 upregulation and their relation to cell fate outcomes Cite
  Christina Y, Frazier K, Rothschild D, Mookerjee S, Brand M, Scott G, et al. Abstract 215: Metabolic and mitochondrial consequences of p53 upregulation and their relation to cell fate outcomes. Molecular and Cellular Biology, Genetics. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-215
• Differential Effects of Organic and Inorganic Mercury on Phenotypically Variant Breast Cancer Cell Lines Cite
  R Wallace D. Differential Effects of Organic and Inorganic Mercury on Phenotypically Variant Breast Cancer Cell Lines. Journal of Clinical Toxicology. OMICS Publishing Group; 2016; 05 10.4172/2161-0495.1000273
• Effect of Crocin on Cell Cycle Regulators in N-Nitroso-N-Methylurea-Induced Breast Cancer in Rats Cite
  Ashrafi M, Bathaie SZ, Abroun S, Azizian M. Effect of Crocin on Cell Cycle Regulators in N-Nitroso-N-Methylurea-Induced Breast Cancer in Rats. DNA and Cell Biology. Mary Ann Liebert Inc; 2015; 34:684-691 10.1089/dna.2015.2951
• Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival Cite
  Lee SK, Bae SY, Lee JH, Lee H, Yi H, Kil WH, et al. Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0124658 10.1371/journal.pone.0124658
• p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells Cite
  Li P, Zhao M, Parris AB, Feng X, Yang X. p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells. Biochemical and Biophysical Research Communications. Elsevier BV; 2015; 464:1267-1274 10.1016/j.bbrc.2015.07.117
• Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer Cite
  Kim T, Han W, Kim MK, Lee JW, Kim J, Ahn SK, et al. Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. Journal of Breast Cancer. Korean Breast Cancer Society; 2015; 18:16 10.4048/jbc.2015.18.1.16
• Thymoquinone, A Bioactive Component of Black Caraway Seeds, Causes G1 Phase Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells with Mutant p53 Cite
  Sutton KM, Greenshields AL, Hoskin DW. Thymoquinone, A Bioactive Component of Black Caraway Seeds, Causes G1 Phase Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells with Mutant p53. Nutrition and Cancer. Informa UK Limited; 2014; 66:408-418 10.1080/01635581.2013.878739
• Dietary downregulation of mutant p53 levels via glucose restriction Cite
  Rodriguez OC, Choudhury S, Kolukula V, Vietsch EE, Catania J, Preet A, et al. Dietary downregulation of mutant p53 levels via glucose restriction. Cell Cycle. Informa UK Limited; 2012; 11:4436-4446 10.4161/cc.22778
• Tumour characteristics among women with very low-risk breast cancer Cite
  Narod SA, Valentini A, Nofech-Mozes S, Sun P, Hanna W. Tumour characteristics among women with very low-risk breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 134:1241-1246 10.1007/s10549-012-2065-x
• Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway Cite
  Freed-Pastor W, Mizuno H, Zhao X, Langerød A, Moon S, Rodriguez-Barrueco R, et al. Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway. Cell. Elsevier BV; 2012; 148:244-258 10.1016/j.cell.2011.12.017
• Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro Cite
  Xiao J, Sun G, Sun B, Wu Y, He L, Wang X, et al. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Toxicology. Elsevier BV; 2012; 292:53-62 10.1016/j.tox.2011.11.018
• Curcumin Enhances the Efficacy of Chemotherapy by Tailoring p65NFκB-p300 Cross-talk in Favor of p53-p300 in Breast Cancer Cite
  Sen GS, Mohanty S, Hossain DMS, Bhattacharyya S, Banerjee S, Chakraborty J, et al. Curcumin Enhances the Efficacy of Chemotherapy by Tailoring p65NFκB-p300 Cross-talk in Favor of p53-p300 in Breast Cancer. Journal of Biological Chemistry. American Society for Biochemistry & Molecular Biology (ASBMB); 2011; 286:42232-42247 10.1074/jbc.m111.262295
• Effect of flavonone hesperidin on the apoptosis of human mammary carcinoma cell line MCF-7 Cite
  Natarajan N, Thamaraiselvan R, Lingaiah H, Srinivasan P, Maruthaiveeran Periyasamy B. Effect of flavonone hesperidin on the apoptosis of human mammary carcinoma cell line MCF-7. Biomedicine & Preventive Nutrition. Elsevier BV; 2011; 1:207-215 10.1016/j.bionut.2011.07.001
• Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy Cite
  Chiu S. Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy. International Journal of Oncology. Spandidos Publications; 2011; 10.3892/ijo.2011.1203
• β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation Cite
  Park K, Nam D, Yun H, Lee S, Jang H, Sethi G, et al. β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Letters. Elsevier BV; 2011; 312:178-188 10.1016/j.canlet.2011.08.001
• Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line-specific apoptotic mechanisms Cite
  Rao PS, Satelli A, Moridani M, Jenkins M, Rao US. Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line-specific apoptotic mechanisms. International Journal of Cancer. Wiley; 2011; 130:2703-2714 10.1002/ijc.26308
• Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype Cite
  Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes & Control. Springer Science and Business Media LLC; 2011; 22:965-975 10.1007/s10552-011-9769-9
• Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: An in silico and biochemical approach targeting integrin αvβ3 Cite
  Hsieh T, Wong C, John Bennett D, Wu JM. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: An in silico and biochemical approach targeting integrin αvβ3. International Journal of Cancer. Wiley; 2011; 129:2732-2743 10.1002/ijc.25930
• Hsp27 Protects Adenocarcinoma Cells from UV-Induced Apoptosis by Akt and p21-Dependent Pathways of Survival Cite
  Kanagasabai R, Karthikeyan K, Vedam K, Qien W, Zhu Q, Ilangovan G. Hsp27 Protects Adenocarcinoma Cells from UV-Induced Apoptosis by Akt and p21-Dependent Pathways of Survival. Molecular Cancer Research. American Association for Cancer Research (AACR); 2010; 8:1399-1412 10.1158/1541-7786.mcr-10-0181
• p53-Independent Apoptosis by Benzyl Isothiocyanate in Human Breast Cancer Cells Is Mediated by Suppression of XIAP Expression Cite
  Kim S, Singh SV. p53-Independent Apoptosis by Benzyl Isothiocyanate in Human Breast Cancer Cells Is Mediated by Suppression of XIAP Expression. Cancer Prevention Research. American Association for Cancer Research (AACR); 2010; 3:718-726 10.1158/1940-6207.capr-10-0048
• Associations between Polycyclic Aromatic Hydrocarbon–Related Exposures andp53Mutations in Breast Tumors Cite
  Mordukhovich I, Rossner P, Terry MB, Santella R, Zhang Y, Hibshoosh H, et al. Associations between Polycyclic Aromatic Hydrocarbon–Related Exposures andp53Mutations in Breast Tumors. Environmental Health Perspectives. Environmental Health Perspectives; 2010; 118:511-518 10.1289/ehp.0901233
• Use of Four Biomarkers to Evaluate the Risk of Breast Cancer Subtypes in the Women's Contraceptive and Reproductive Experiences Study Cite
  Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, Spirtas R, et al. Use of Four Biomarkers to Evaluate the Risk of Breast Cancer Subtypes in the Women's Contraceptive and Reproductive Experiences Study. Cancer Research. American Association for Cancer Research (AACR); 2010; 70:575-587 10.1158/0008-5472.can-09-3460
• Antiproliferative Effects of Honey and of Its Polyphenols: A Review Cite
  Jaganathan SK, Mandal M. Antiproliferative Effects of Honey and of Its Polyphenols: A Review. Journal of Biomedicine and Biotechnology. Hindawi Limited; 2009; 2009:1-13 10.1155/2009/830616
• Canola Oil Inhibits Breast Cancer Cell Growth in Cultures and In Vivo and Acts Synergistically with Chemotherapeutic Drugs Cite
  Cho K, Mabasa L, Fowler AW, Walsh DM, Park CS. Canola Oil Inhibits Breast Cancer Cell Growth in Cultures and In Vivo and Acts Synergistically with Chemotherapeutic Drugs. Lipids. Wiley; 2010; 45:777-784 10.1007/s11745-010-3462-8
• Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells Cite
  Ramljak D, Romanczyk LJ, Metheny-Barlow LJ, Thompson N, Knezevic V, Galperin M, et al. Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells. Molecular Cancer Therapeutics. American Association for Cancer Research (AACR); 2005; 4:537-546 10.1158/1535-7163.mct-04-0286